DEENOVA
3.5.2022 07:02:13 CEST | Business Wire | Press release
Today, Deenova announced that it is launching its innovative Pay-Per-Dose unit dose pharmacy automation service to the UK market for the first time. Deenova was the first company to bring a fully automated, closed-loop solution for the management of medication and medical supplies to the UK following a hugely successful pilot at University Hospitals Leicester . This newly designed Pay-Per-Dose solution is initially offered in late 2022 for the Greater London Metropolitan Area to both NHS and private hospitals. Deenova thus opens its market reach to short-term and easy-to-adopt contractual arrangements and flexibility in England´s Pharmacy Automation market.
Deenova is making the unit dose concept a reality in the UK. Its end-to-end pharmacy automation service not only personalises medicine dispensation and administration to individual patients, but enables closed-loop medication management; fully tracking and managing medicines from prescription, through to patient administration. This innovative approach promises to ease growing pressures on healthcare providers in the UK by increasing patient safety, reducing treatment dispensing errors and medicine waste, containing costs, and saving nurses’ and pharmacists’ time. This approach promises to ease growing pressures on healthcare providers in the UK by increasing patient safety, reducing treatment dispensing errors and medicine waste, containing costs, and saving nurses’ and pharmacists’ time.
Gaspar G. De Viedma , Vice Chairman of the Board of Directors at Deenova stated: “I am very bullish about this exciting new venture, especially on the heels of our 15-year award from University Hospitals of Leicester NHS Trust in Europe´s second largest GDP healthcare market, and after the first ever successful unit dose implementation in the United Kingdom. The patient safety and economic advantages of Deenova ´s unique closed-loop medication unit dose system were already clearly evidenced by the positive evaluation report issued by the East Midlands Academic Health Science Network (AHSN) following an 18-month evaluation of Deenova ’s closed-loop solutions.”
The new pay-per-dose unit dose pharmacy automation is a full service, yet modular solution. It includes Deenova’s ORBIT Software for e-prescribing and micro-logistic management, all IT infrastructure hosting and integration with hospital Health Information Systems (HIS), its proprietary and award winning mechatronic devices for the production of unit doses , and the All-In-1 Station - a fully automated solution for the dispensation of personalised therapies. Deenova ’s pay-per-dose service also includes staff to manage the full medication traceability process, as well all support functions such as training, maintenance, hot line support, analytics and reporting.
Deenova will officially launch its pay-per-dose unit dose pharmacy automation solution during the UK Clinical Pharmacy Congress at the lunch time symposia show, floor theatre, Friday 13 May at 1:00pm.
Christophe Jaffuel , Deenova´s Chief Commercial Officer, added: “Deenova has been delivering end-to-end unit dose solutions across Europe for decades. I look forward to personally working with English hospitals in the Greater London Metropolitan Area, and with our newly appointed UK Commercial Director Andrew Lyon in making these extremely flexible and cost effective solutions a successful reality for Deenova .”
About Deenova
Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere. Deenova’s unique, patented, and fully integrated solutions have and will greatly ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff.
Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.
Deenova have been delivering unit dose solutions provided as a complete end-to-end service to hospitals across Europe for 18 years, with more than 70 projects to date - partnering with regional healthcare trusts to deliver results at scale.
Please visit www.deenova.com for additional information on its market-leading solutions.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220502005779/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Azizi Developments Introduces USD 8.1 Billion Master-Planned Community Azizi Florence in Sharjah10.9.2026 16:08:00 CEST | Press release
Azizi Developments, a leading private developer in the UAE, is unveiling Azizi Florence, a USD 8.1 billion master-planned community marking its first project in Sharjah. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260910091949/en/ Azizi Florence (Photo: AETOSWire) The freehold development will feature 1,130 villas, more than 6,000 townhouses and 3,500 apartments, with three-bedroom townhouses starting from USD 515,000 at USD 231 per square foot of sellable area. Designed as an integrated destination, Azizi Florence will bring together residential, retail, hospitality, education, leisure and wellness offerings, centred around a 1.7-million-square-foot Central Park. Six residential clusters will each feature a park, clubhouse, community centre and landscaped gardens. Mr. Mirwais Azizi, Founder and Chairman of Azizi Group, said: “Returning to Sharjah after more than three decades is deeply meaningful to me, as this emirate w
Agentic Crypto Payments Have Surged by 500%1 in the Last Three Months, Crypto Compliance Must Become Agentic Too10.9.2026 15:53:00 CEST | Press release
Elliptic is publishing eight principles for governing agentic on-chain risk: the Elliptic Standard Elliptic,the global leader in on-chain risk, today published the Elliptic Standard: eight principles for governing agentic on-chain risk. Elliptic has been at the intersection of financial crime and on-chain finance since 2013, long enough to recognize the shift to agentic transactions as a defining inflection point in financial crime risk, and to be the first to define what governing it demands. On-chain finance is now running at agentic speed. Machines are originating, authorizing and settling transactions at a volume no human team can review. Illicit actors are using AI to evade detection at a speed and volume that manual processes cannot track. Models built around human review were never designed for this world. They are already overwhelmed. Three forces are driving this shift. First, autonomous agents are increasingly the counterparty on both sides of a transaction, not just people i
Wasabi Establishes AI Business in Silicon Valley, Taps Pinaki Mukherjee to Lead as Senior Vice President & General Manager10.9.2026 15:00:00 CEST | Press release
Semiconductor and storage veteran to lead dedicated AI business to accelerate the independent storage foundation for AI labs, startups, and neocloud push as data demand grows to unprecedented scale Wasabi Technologies, the hot cloud storage company, today announced the formation of a dedicated AI business, and the appointment of semiconductor and storage veteran Pinaki Mukherjee as senior vice president and general manager to lead it. Wasabi stores hundreds of petabytes of AI data for frontier model labs, generative AI startups, and neocloud compute providers worldwide. This new AI business brings dedicated strategy, partnerships and go-to-market focus for this demand as AI infrastructure matures. “Mukherjee has a track record of driving the kind of high-value partnerships that move markets, and that’s exactly what this moment requires,” said Marty Falaro, president and COO of Wasabi. “AI workloads are pushing storage demand to a scale we've never seen, and Mukherjee is the right perso
Ant Group’s AI Health App AQ Reaches 150 Million Users as It Expands AI-powered Day-to-day Health Use Cases10.9.2026 14:47:00 CEST | Press release
At the 2026 INCLUSION · Conference on the Bund in Shanghai, Zhang Junjie, Vice President of Ant Group and Head of the Health Business, announced that Ant Group’s flagship AI health app AQ has reached 150 million users, handling nearly 20 million health inquiries per day. The new milestone also means AQ has grown its user base by 50% in just 8 months, since it announced 100 million users in February 2026, reflecting strong demand in China’s AI health space. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260910921103/en/ Ant Group’s AI health app AQ provides personalized health advice based on more than 10 health indicators. Health has become an increasingly important priority among Chinese consumers. According to Accenture’s China Consumer Insights report published in November 2025, the share of Chinese consumers who considered health a priority increased from 78% in 2021 to 87% in 2025, making it the top priority among the a
AULUMU Introduces A18 Series for iPhone 18 With Aramid Fibre, Hybrid Protection and Distinctive Finishes10.9.2026 14:43:00 CEST | Press release
Technology accessories brand aulumu has introduced the A18 Series for iPhone 18, a new collection of smartphone cases designed around lightweight protection, material innovation and distinctive visual finishes. The range includes the A18 Armor Shockproof Aramid Fiber Case, two ultra-slim aramid fibre models, the Ghost Lumen Transparent Case, and the Particle Vegan Leather Case. At the centre of the collection, the A18 Armor combines 1500D aramid fibre and thermoplastic polyurethane (TPU) in a one-piece construction. The hybrid structure pairs the light weight and woven texture of aramid fibre with the flexibility and cushioning properties of TPU. A full-wrap design covers the phone’s edges, while reinforced corners are intended to help distribute impact from everyday drops and bumps. The case is designed to provide drop protection from heights of up to 2 metres, with a 1.36 mm raised screen edge and a 1.3 mm raised camera frame providing additional protection around key areas. The A18
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom